Drug­maker Glaxo shuts down plant over Le­gion­naires’ con­cerns

The China Post - - LIFE GUIDE POST - BY EMERY P. DALE­SIO

Drug­maker Glax­oSmithK­line shut down a plant Tues­day that pro­duces in­haled med­i­ca­tions af­ter dis­cov­er­ing the bac­te­ria that causes Le­gion­naire’s dis­ease, a po­ten­tially fa­tal form of pneu­mo­nia.

The man­u­fac­tur­ing plant in Ze­bu­lon, about 40 kilo­me­ters east of Raleigh, was closed af­ter rou­tine test­ing found the bac­te­ria in a self­s­tand­ing cool­ing tower. About 400 of the 850 em­ploy­ees who work in Ze­bu­lon were told to stay away un­til the tow­ers are cleaned, of­fi­cials for the Lon­don-based com­pany said.

The com­pany said in a state­ment that the cool­ing tower “does not come into con­tact with prod­uct man­u­fac­tured at the fa­cil­ity.” Glaxo did not re­spond to ques­tions about whether there was any risk of in­door ex­po­sure to em­ploy­ees or medicines from wa­ter droplets that could carry the bac­te­ria.

“We are try­ing to gather in­for­ma­tion on what the sit­u­a­tion is,” spokes­woman Jenni Brewer Lig­day said. Test­ing is con­ducted ev­ery three months, but the com­pany was seek­ing “more de­tails on whether prod­uct has been im­pacted and, if they have, what is our pro­ce­dure in place to han­dle that.”

Newspapers in English

Newspapers from Taiwan

© PressReader. All rights reserved.